HCW9302 — Full data
Q4 2026
The full Phase 1 human data readout for the HCW9302 study remains on track to be released in the fourth quarter of 2026.Source filing
HCWB biotech catalysts & pipeline
HCW BIOLOGICS INC · Data as of 2026-10-25
Upcoming catalysts
HCW11-018b — IND submission
H1 2027
The Company intends to file an IND-application to seek authorization to evaluate HCW11-018b in a Phase 1 clinical study in patients with cancer in the first half of 2027, and an IND-application to seek authorization to evaluate HCW11-040 in bronchopulmonary dysplasia, a chronic lung disease primarily affecting premature infants, in the second half of 2027.Source filing
HCW11-040 — IND submission
H2 2027
The Company intends to file an IND-application to seek authorization to evaluate HCW11-040 in bronchopulmonary dysplasia, a chronic lung disease primarily affecting premature infants, in the second half of 2027, and an IND-application to seek authorization to evaluate HCW11-040 in bronchopulmonary dysplasia, a chronic lung disease primarily affecting premature infants, in the second half of 2027.Source filing